Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

IHMT-PI3Kδ-372

🥰Excellent
Catalog No. T35530Cas No. 2429889-62-1
Alias IHMT-PI3Kδ-372

IHMT-PI3Kδ-372 is a selective inhibitor of PI3Kδ with an IC50 of 14 nM and can be used in studies about chronic obstructive pulmonary disease.

IHMT-PI3Kδ-372

IHMT-PI3Kδ-372

🥰Excellent
Purity: 99.54%
Catalog No. T35530Alias IHMT-PI3Kδ-372Cas No. 2429889-62-1
IHMT-PI3Kδ-372 is a selective inhibitor of PI3Kδ with an IC50 of 14 nM and can be used in studies about chronic obstructive pulmonary disease.
Pack SizePriceAvailabilityQuantity
1 mg$30In Stock
5 mg$68In Stock
10 mg$107In Stock
25 mg$176In Stock
50 mg$262In Stock
100 mg$355In Stock
1 mL x 10 mM (in DMSO)$71In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "IHMT-PI3Kδ-372"

Select Batch
Purity:99.54%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
IHMT-PI3Kδ-372 is a selective inhibitor of PI3Kδ with an IC50 of 14 nM and can be used in studies about chronic obstructive pulmonary disease.
Targets&IC50
PI3Kδ:14 nM (IC50), CYP2C9:2.7 μM (IC50)
In vitro
In Raji cells, IHMT-PI3Kδ-372 (0.03-3 μM) inhibits PI3Kδ-mediated AKT T308 phosphorylation (EC50 = 67 nM).IHMT-PI3Kδ-372 moderately inhibits CYP2C9 (IC50 = 2.7 μM) and no apparently inhibits CYP1A2, CYP2B6, CYP2C19, and CYP3A4 (IC50s > 10 μM)[1].
In vivo
IHMT-PI3Kδ-372 (1-5 mg/kg; inhalation) improves lung function and reduced the inflammatory patterns characteristic of COPD with better forced expiratory volume in FEV1, FVC, and PEF. IHMT-PI3Kδ-372 dose-dependently decreases the inflammatory cell and reduces the abnormally high level of leukocytes including the alveolar macrophages, neutrophils, and lymphocytes. In rats, IHMT-PI3Kδ-372 (5 mg/kg; inhalation) displays a half-life of 2.3 h, low exposure of 66 ng/mL, and high clearance of 348.5 mL/min/kg in plasma and high exposure of 5599 ng/g (6 h after inhalation) in lung tissue[1].
AliasIHMT-PI3Kδ-372
Chemical Properties
Molecular Weight503.5
FormulaC26H23F2N7O2
Cas No.2429889-62-1
SmilesCC[C@H](c1nc2cccc(F)c2c(=O)n1C1CC1)n1nc(-c2ccc(OC)c(F)c2)c2c(N)ncnc12
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 37.8 mg/mL (75.1 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9861 mL9.9305 mL19.8610 mL99.3049 mL
5 mM0.3972 mL1.9861 mL3.9722 mL19.8610 mL
10 mM0.1986 mL0.9930 mL1.9861 mL9.9305 mL
20 mM0.0993 mL0.4965 mL0.9930 mL4.9652 mL
50 mM0.0397 mL0.1986 mL0.3972 mL1.9861 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy IHMT-PI3Kδ-372 | purchase IHMT-PI3Kδ-372 | IHMT-PI3Kδ-372 cost | order IHMT-PI3Kδ-372 | IHMT-PI3Kδ-372 chemical structure | IHMT-PI3Kδ-372 in vivo | IHMT-PI3Kδ-372 in vitro | IHMT-PI3Kδ-372 formula | IHMT-PI3Kδ-372 molecular weight